Guenova E, Schanz S, Hoetzenecker W, DeSimone JA, Mehra T, Voykov B, Urosevic-Maiwald M, Berneburg M, Dummer R, French LE, et al. Systemic corticosteroids for subcutaneous panniculitis-like T-cell lymphoma. Br J Dermatol. 2014;171(4):891–4. https://doi.org/10.1111/bjd.13053.
Article
CAS
Google Scholar
Brown NA, Ross CW, Gudjonsson JE, Wale D, Pawarode A, Maillard I, Hristov AC. Subcutaneous panniculitis like T-cell lymphoma with bone marrow involvement. Am J Clin Pathol. 2015;143(2):265–73. https://doi.org/10.1309/AJCPVZYB19NEDXXZ.
Article
Google Scholar
Willemze R, Jansen PM, Cerroni L, Berti E, Santucci M, Assaf C, Canninga-van Dijk MR, Carlotti A, Geerts ML, et al. Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC cutaneous Lymphoma group study of 83 cases. Blood. 2008;111(2):838–45. https://doi.org/10.1182/blood-2007-040087288.
Article
CAS
Google Scholar
Lee DW, Yang JH, Lee SM, Won CH, Chang S, Lee MW, Choi JH, Moon KC. Subcutaneous panniculitis-like T-cell lymphoma: a clinical and pathologic study of 14 Korean patients. Ann Dermatol. 2011;23:329–37. https://doi.org/10.5021/ad.2011.23.3.329.
Article
Google Scholar
Kong YY, Dai B, Kong JC, Zhou XY, Lu HF, Shen L, Du X, Shi DR. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO- EORTC classification. Am J Surg Pathol. 2008;32:1495–502. https://doi.org/10.1097/PAS.0b013e31817a9081.
Article
Google Scholar
Hoque SR, Child FJ, Whittaker SJ, Ferreira S, Orchard G, Jenner K, et al. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of six patients. Br J Dermatol. 2003;148:516–25. https://doi.org/10.1111/cas.12439.
Article
CAS
Google Scholar
Iqbal N, Raina V. Successful treatment of disseminated subcutaneous panniculitis- like T-cell lymphoma with single agent oral cyclosporine as a first line therapy. Case Rep Dermatol Med. 2014;2014:201836. https://doi.org/10.1155/2014/201836.
Article
Google Scholar
Lee WS, Hwang JH, Kim MJ, Go SI, Lee A, Song HN, Lee MJ, Kang MH, Kim HG, Lee JH. Cyclosporine A as a primary treatment for panniculitis-like T Cell lymphoma: a case with a long-term remission. Cancer Res Treat. 2014;46(3):312–6. https://doi.org/10.4143/crt.2014.46.3.312.
Article
CAS
Google Scholar
Chen CC, Teng CL, Yeh SP. Relapsed and refractory panniculitis-like T-cell lymphoma with excellent response to cyclosporine: a case report and literature review. Ann Hematol. 2016;95(5):837–40. https://doi.org/10.1007/s00277-016-2615-0.
Article
Google Scholar
Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, Ralfkiaer E, Chimenti S, Diaz-Perez JL, Duncan LM, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768–85. https://doi.org/10.1182/blood-2004-09-3502.
Article
CAS
Google Scholar
Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124–31. https://doi.org/10.1002/pbc.21039.
Article
Google Scholar
National Cancer Institute. CTEP: NCI guidance on CTC terminology applications. Bethesda: National Cancer Institute; 2006.
Google Scholar
Juweid ME, Stroobants S, Hoekstra OS, Mottaghy FM, Dietlein M, Guermazi A, Wiseman GA, Kostakoglu L, Scheidhauer K, Buck A, et al. Use of positron emission tomography for response assessment of lymphoma: consensus of imaging Subcommittee of International Harmonization project in lymphoma. J Clin Oncol. 2007;25(5):571–8. https://doi.org/10.1200/JCO.2006.08.2305.
Article
Google Scholar
Soylu S, Gül U, Kiliç A, Okçu-Heper A, Kuzu I, Gönen-Minareci B. A case with an indolent course of subcutaneous panniculitis-like T-cell lymphoma demonstrating Epstein-Barr virus positivity and simulating dermatitis artefacta. Am J Clin Dermatol. 2010;11(2):147–50. https://doi.org/10.2165/11311060-000000000-00000.
Article
Google Scholar
Salhany KE, Macon WR, Choi JK, Elenitsas R, Lessin SR, Felgar RE, et al. Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alpha/beta and gamma/delta subtypes. Am J Surg Pathol. 1998;22(7):881–93. https://doi.org/10.1097/00000478-199807000-00010.
Article
CAS
Google Scholar
Huppmann AR, Xi L, Raffeld M, Pittaluga S, Jaffe ES. Subcutaneous panniculitis- like T-cell lymphoma in the pediatric age group: a lymphoma of low malignant potential. Pediatr Blood Cancer. 2013;60:1165–70. https://doi.org/10.1002/pbc.24462.
Article
Google Scholar
Polprasert C, Takeuchi Y, Kakiuchi N, Yoshida K, Assanasen T, Sitthi T, et al. Frequent germline mutations of HAVCR2 in sporadic subcutaneous panniculitis-like T-cell lymphoma. Blood Adv. 2019;3(4):588–95. https://doi.org/10.1182/bloodadvances.2018028340.
Article
CAS
Google Scholar
Wegehaupt O, Groβ M, Wehr C, Marks R, Schmitt-Graeff A, Uhl M, Lorenz M, Schwarz K, Kratz C, Niemeyer C, et al. TIM-3 deficiency presenting with two clonally unrelated episodes of mesenteric and subcutaneous panniculitis-like T- cell lymphoma and hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2020;67(6):e28302. https://doi.org/10.1002/pbc.28302.
Article
Google Scholar
Gayden T, Sepulveda FE, Khuong-Quang DA, Pratt J, Valera ET, Garrigue A, Kelso S, Sicheri F, Mikael LG, Hamel N, et al. Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic syndrome. Nat Genet. 2018;50:1650–7. https://doi.org/10.1038/s41588-018-0251-4.
Article
CAS
Google Scholar
Polprasert C, Takeuchi Y, Kakiuchi N, Yoshida K, Assanasen T, Sitthi W, Bunworasate U, Pirunsarn A, Wudhikarn K, Lawasut P, et al. Frequent germline mutations of HAVCR2 in sporadic subcutaneous panniculitis-like T cell lymphoma. Blood Adv. 2019;3:588–95. https://doi.org/10.1182/bloodadvances.2018028340.
Article
CAS
Google Scholar
Gayden T, Sepulveda FE, Khuong-Quang DA, Pratt J, Valera ET, Garrigue A, Kelso S, Sicheri F, Mikael LG, Hamel N, et al. Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome. Nat Genet. 2018. https://doi.org/10.1038/s41588-018-0251-4.
Article
Google Scholar
Sonigo G, Battistella M, Beylot-Barry M, Ingen-Housz-Oro S, Franck N, Barete S, Boulinguez S, Dereure O, Bonnet N, Socié G, et al. HAVCR2 mutations are associated with severe hemophagocytic syndrome in subcutaneous panniculitis-like T- cell lymphoma. Blood. 2020. https://doi.org/10.1182/blood.2019003811.
Article
Google Scholar
Willemze R, Jansen PM, Cerroni L, Berti E, Santucci M, Assaf C, et al. Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83. Blood. 2008;111:838–45. https://doi.org/10.1182/blood-2007-04-087288.
Article
CAS
Google Scholar
Lee D-W, Yang J-H, Lee S-M, Won C-H, Chang S, Lee M-W, et al. Subcutaneous panniculitis-like T-cell lymphoma: a clinical and pathologic study of 14 Korean patients. Ann Dermatol. 2011;23:329–37. https://doi.org/10.5021/ad.2011.23.3.329.
Article
Google Scholar
Musick SR, Lynch DT. Subcutaneous panniculitis like T-cell lymphoma. Elsevier; 1600 John F. Kennedy Blvd; Ste. 1600; Philadelphia, PA 19103-2899: StatPearls Publishing. 2022.
Nagai K, Nakano N, Iwai T, Iwai A, Tauchi H, Ohshima K, Ishii E. Pediatric subcutaneous panniculitis-like T-cell lymphoma with favorable result by immunosuppressive therapy: a report of two cases. Pediatr Hematol Oncol. 2014;31(6):528–33. https://doi.org/10.3109/08880018.2014.896062.
Article
CAS
Google Scholar
Rojnuckarin P, Nakorn TN, Assanasen T, Wannakrairot P, Intragumtornchai T. Cyclosporin in subcutaneous panniculitis-like T-cell lymphoma. Leuk Lymphoma. 2007;48:560–3. https://doi.org/10.1080/10428190601078456.
Article
CAS
Google Scholar
Michonneau D, Petrella T, Ortonne N, Ingen-Housz-Oro S, Franck N, Barete S, Battistella M, Beylot-Barry M, Vergier B, Maynadié M, et al. Subcutaneous panniculitis-like T-cell lymphoma: immunosuppressive drugs induce better response than polychemotherapy. Acta Derm Venereol. 2017;97(3):358–64. https://doi.org/10.2340/00015555-2543.
Article
Google Scholar
Aragon-Miguel R, Calleja-Algarra A, Velasco-Tamarize V, Garrido M, Ortiz- Romero P, Maroñas-Jimé Nez N. Is cyclosporine a good option for the treatment of subcutaneous panniculitis-like T-cell lymphoma associated with hemophagocytic syndrome. Indian J Dermatol Venereol Leprol. 2019;85(6):656–9. https://doi.org/10.4103/ijdvl.IJDVL_747_18.
Article
Google Scholar